Table 1.
Schizophrenia (SZ) | Healthy Control Subjects (HS) | ||||||
---|---|---|---|---|---|---|---|
Total (n=21) | HSV1− (n=11) |
HSV1+ (n=10) |
Total (n=19) | HSV1− (n=13) | HSV1+ (n=6) | ||
Age (in years)1 Mean ± SD |
24.16±8.63 | 21.34±6.21 | 27.26±10.11 | 24.39±6.29 | 23.89±6.01 | 25.48±7.32 | |
Gender2 | Male | 17 | 10 | 7 | 6 | 6 | 0 |
Female | 4 | 1 | 3 | 13 | 7 | 6 | |
Av SES3 | 41.38±14.66 | 40.36±12.93 | 42.50±17.01 | 46.55±11.16 | 46.46 (11.78) | 46.75 (10.71) | |
MICB Genotypes |
GG | 9 | 3 | 6 | 7 | 1 | 6 |
AG | 12 | 7 | 5 | 12 | 5 | 7 | |
AA | 0 | 0 | 0 | 0 | 0 | 0 |
HSV1: Herpes Simplex Virus, Subtype 1; SES: Socio-economic Status
t-tests:
SZ and HS did not differ in age. Similarly, HSV1+ SZ and HSV1− SZ subjects (t=1.63 p=0.12), and HSV1+ Controls and HSV1− Controls (t=0.50 p=0.62) did not differ in age
There were more females among HS (χ2=9.95, p=0.003)
SES did not differ between SZ and HS (t=1.26, p=0.22). In addition, HSV1+ SZ and HSV1− SZ subjects (t=0.33 p=0.75), and HSV1+ Controls and HSV1− SZ Controls did not differ in SES (t=0.05, p=0.96)